Education
About Us
Working with TipRanks
Follow Us
Molecule Holdings (TSE:MLCL)
:MLCL
Total Valuation
Molecule Holdings has a market cap or net worth of C$488.91K. The enterprise value is C$9.48M.
Market CapC$488.91K
Enterprise ValueC$9.48M
Share Statistics
Molecule Holdings has 97,781,906 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding97,781,906
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Molecule Holdings’s return on equity (ROE) is 1.23 and return on invested capital (ROIC) is -250.72%.
Return on Equity (ROE)1.23
Return on Assets (ROA)-1.16
Return on Invested Capital (ROIC)-250.72%
Return on Capital Employed (ROCE)1.08
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.50
Inventory Turnover5.01
Valuation Ratios
The current PE Ratio of Molecule Holdings is -0.96. Molecule Holdings’s PEG ratio is 0.08.
PE Ratio-0.96
PS Ratio0.00
PB Ratio-1.18
Price to Fair Value-1.18
Price to FCF-3.76
Price to Operating Cash Flow-3.87
PEG Ratio0.08
Income Statement
In the last 12 months, Molecule Holdings had revenue of 1.97M and earned -4.54M in profits. Earnings per share was -0.05.
Revenue1.97M
Gross Profit-1.07M
Operating Income-3.91M
Pretax Income-4.54M
Net Income-4.54M
EBITDA-3.87M
Earnings Per Share (EPS)-0.05
Cash Flow
In the last 12 months, operating cash flow was -98.67K and capital expenditures 0.00, giving a free cash flow of -98.67K billion.
Operating Cash Flow-98.67K
Free Cash Flow-98.67K
Free Cash Flow per Share>-0.01
Dividends & Yields
Molecule Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.26
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)―
Average Volume (3m)0.00
Important Dates
Molecule Holdings upcoming earnings date is Sep 26, 2024, TBA Not Confirmed.
Last Earnings DateJun 27, 2024
Next Earnings DateSep 26, 2024
Ex-Dividend Date―
Financial Position
Molecule Holdings as a current ratio of 0.17, with Debt / Equity ratio of -140.63%
Current Ratio0.17
Quick Ratio0.09
Debt to Market Cap1.17
Net Debt to EBITDA-1.32
Interest Coverage Ratio-6.17
Taxes
In the past 12 months, Molecule Holdings has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Molecule Holdings EV to EBITDA ratio is -2.45, with an EV/FCF ratio of -8.16.
EV to Sales4.82
EV to EBITDA-2.45
EV to Free Cash Flow-8.16
EV to Operating Cash Flow-8.40
Balance Sheet
Molecule Holdings has C$141.93K in cash and marketable securities with C$5.83M in debt, giving a net cash position of C$5.69M billion.
Cash & Marketable SecuritiesC$141.93K
Total DebtC$5.83M
Net CashC$5.69M
Net Cash Per ShareC$0.06
Tangible Book Value Per Share-C$0.04
Margins
Gross margin is -54.56%, with operating margin of -198.86%, and net profit margin of -230.84%.
Gross Margin-54.56%
Operating Margin-198.86%
Pretax Margin-230.84%
Net Profit Margin-230.84%
EBITDA Margin-196.57%
EBIT Margin-198.59%
Analyst Forecast
The average price target for Molecule Holdings is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―